Fatigue in Inflammatory Joint Diseases.
Grzegorz ChmielewskiMichał S MajewskiJakub KunaMateusz MikiewiczMagdalena Krajewska-WłodarczykPublished in: International journal of molecular sciences (2023)
Fatigue is a prevalent symptom in various rheumatic diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is characterised as a subjective, enduring feeling of generalised tiredness or exhaustion, impacting the patient's life quality and exacerbating disability. The fatigue nature is multifaceted, encompassing physiological, psychological, and social factors, and although the exact cause of inflammatory joint diseases is not fully understood, several factors are believed to contribute to its development. Despite high prevalence and importance, the symptom is often underestimated in clinical practice. Chronic inflammation, commonly associated with rheumatic diseases, has been proposed as a potential contributor to fatigue development. While current treatments effectively target inflammation and reduce disease activity, fatigue remains a persistent problem. Clinical evaluation of rheumatic diseases primarily relies on objective criteria, whereas fatigue, being a subjective symptom, is solely experienced and reported by the patient. Managing fatigue in inflammatory joint diseases involves a multifaceted approach. Identifying and comprehensively assessing the subjective components of fatigue in individual patients is crucial for effectively managing this symptom in everyday clinical practice.
Keyphrases
- sleep quality
- disease activity
- rheumatoid arthritis
- ankylosing spondylitis
- oxidative stress
- clinical practice
- systemic lupus erythematosus
- depressive symptoms
- healthcare
- ejection fraction
- physical activity
- multiple sclerosis
- mental health
- newly diagnosed
- patient reported
- prognostic factors
- juvenile idiopathic arthritis